← Return to Weighing the cancer risk reduction & quality-of-life cost of ADT?
DiscussionWeighing the cancer risk reduction & quality-of-life cost of ADT?
Prostate Cancer | Last Active: Feb 13 5:00pm | Replies (123)Comment receiving replies
Replies to "@tango32652 At the monthly Mayo conference yesterday They showed a real interesting PSMA pet comparison of..."
Connect

@jeffmarc Eye opening indeed. I think that 13% life extension they talked about not only incluced what you're showing here, but they also factored in eventual castration resisistence to come up with an average length of lifespan. Thing is, no one is "average". The bell curve on this must be huge.